vimarsana.com

Latest Breaking News On - In one test kit - Page 3 : vimarsana.com

Covid Test Recalled Due to Possible False Negative Results

Cureus | Laboratory and Point-of-Care Testing for COVID-19: A Review of Recent Developments

With the emergence of Coronavirus infection called COVID-19, testing is essential for containment and mitigation purposes. In a pandemic, control is essential to limit the spread of any virus. Initially, contact tracing was not available which ultimately led to the 2020 pandemic. However, with the development of COVID-19 rapid testing, the rate of infections has lessened and has allowed for some return to normalcy. In this review, we discuss the various antibody, antigens, and molecular tests that have been given emergency authorization (EA) from the Food and Drug Administration (FDA). Moreover, we will discuss the various point-of-care tests as well as the specificity and sensitivity that are associated with each testing kit. With appropriate testing, we can be aware of how the virus spreads and how prevalent it remains.

Lucira Health Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Lucira Health Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Lucira Health, Inc (NASDAQ:LHDX) Insider Erik T Engelson Purchases 10,000 Shares of Stock

Lucira Health, Inc. (NASDAQ:LHDX – Get Rating) insider Erik T. Engelson acquired 10,000 shares of the firm’s stock in a transaction dated Thursday, June 16th. The stock was bought at an average cost of $1.49 per share, for a total transaction of $14,900.00. Following the purchase, the insider now directly owns 63,282 shares of the […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.